Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation
Juan Sun, Zhenyuan Huangfu, Jiangtao Yang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114538-114538
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
Shivang Dhoundiyal, Shriyansh Srivastava, Sachin Kumar, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 51
Single-domain antibodies as therapeutics for solid tumor treatment
Mingkai Wang, Tianlei Ying, Yanling Wu
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2854-2868
Open Access | Times Cited: 12
Advances in Radionuclide-Labeled Biological Carriers for Tumor Imaging and Treatment
Yaozhang Yang, Jing Wang, Yan Zhong, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access | Times Cited: 1
Nanotheranostics with Radionuclides for Cancer Diagnosis and Therapy
Minhui Cui, Mengmeng Zhu, Dongsheng Tang, et al.
Advanced Functional Materials (2025)
Closed Access | Times Cited: 1
Linear Peptide-Based PET Tracers for Imaging PD-L1 in Tumors
Lulu Zhang, Siqi Zhang, Wu Jiang, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 8, pp. 4256-4267
Closed Access | Times Cited: 20
PSMA and Sigma-1 receptor dual-targeted peptide mediates superior radionuclide imaging and therapy of prostate cancer
Zhenyuan Huangfu, Jiangtao Yang, Juan Sun, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 767-775
Closed Access | Times Cited: 6
Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
Xiaona Sun, Yuxuan Wu, Xingkai Wang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 345-345
Open Access | Times Cited: 5
Electrochemical separation and purification of no-carrier-added 177Lu for radiopharmaceutical preparation: Translation from bench to bed
Sourav Patra, Rubel Chakravarty, Khajan Singh, et al.
Chemical Engineering Journal Advances (2023) Vol. 14, pp. 100444-100444
Open Access | Times Cited: 11
Brain metastasis: An insight into novel molecular targets for theranostic approaches
Liliana Santos, João Nuno Moreira, Antero Abrunhosa, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104377-104377
Open Access | Times Cited: 4
In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions
Circe D. van der Heide, Hanyue Ma, Mark W. H. Hoorens, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics
Lisa Bokhout, Joana D. Campeiro, Simone U. Dalm
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
High-Affinity NIR-Fluorescent Inhibitors for Tumor Imaging via Carbonic Anhydrase IX
Gediminas Žvinys, Agnė Petrošiūtė, Audrius Zakšauskas, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 6, pp. 790-803
Open Access | Times Cited: 3
Targeted Radionuclide Therapy Activates Prodrugs for Treating Metastasis
Zhibin Guo, Xuanyu Wang, Yi Han, et al.
ACS Central Science (2024) Vol. 10, Iss. 12, pp. 2321-2330
Open Access | Times Cited: 3
Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy
Juan Sun, Jiangtao Yang, Jiakun Guo, et al.
Journal of Controlled Release (2025), pp. 113686-113686
Closed Access
Lanthanide-Based Core-Shell Nanoconstructs for Cancer Theragnostics
Dipak Bari, Vivek Rajkule, S.D. Tiwari, et al.
(2025), pp. 525-544
Closed Access
Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177- radiopharmaceuticals based on antibodies
Maskur, Hendris Wongso, Titis Sekar Humani, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106104-106104
Closed Access | Times Cited: 2
Recent advances of polymeric nanoplatforms for cancer treatment: smart delivery systems (SDS), nanotheranostics and multidrug resistance (MDR) inhibition
Urvashi Gupta, Dipak Maity, Virender K. Sharma
Biomedical Materials (2023) Vol. 19, Iss. 1, pp. 012003-012003
Closed Access | Times Cited: 5
Radioactive and Fluorescent Dual Modality Cysteine Cathepsin B Activity-Based Probe for Cancer Theranostics
Lianbo Zhou, Feng He, Xin Xiang, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 7, pp. 3539-3548
Closed Access | Times Cited: 4
Marriage of radiotracers and total-body PET/CT rapid imaging system: current status and clinical advances.
Yuxuan Wu, Xiaona Sun, Boyang Zhang, et al.
PubMed (2023) Vol. 13, Iss. 5, pp. 195-207
Closed Access | Times Cited: 4
Image-guided drug delivery: Biomedical and imaging advances
Alexandros Marios Sofias, Bing Guo, Jian Xu, et al.
Advanced Drug Delivery Reviews (2024), pp. 115187-115187
Closed Access | Times Cited: 1
Beyond Small Molecules: Antibodies and peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
Xiaona Sun, Yuxuan Wu, Xingkai Wang, et al.
(2024)
Open Access | Times Cited: 1
Development of Radiolabeled Probes with Improved Imaging Contrast by Releasing Urinary Excretable Radiolabeled Compounds from Thermosensitive Liposomes in the Blood
Masayuki Munekane, Masanobu Ozaki, Yusuke Mitani, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 1
Recent Advances in Pretargeted Strategy for Cancer Theranostics
Yuyang Tian, Zheng Huang, Jie-wei Luo, et al.
ChemMedChem (2024) Vol. 19, Iss. 22
Closed Access | Times Cited: 1
Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy
Yichen Guo, Rong Ma, Mengzhe Zhang, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1440-1440
Open Access | Times Cited: 2
Elucidating the linagliptin and human fibroblast activation protein binding mechanism through molecular dynamics and binding free energy analysis
Mingsong Shi, Fang Wang, Lu Zhou, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111368-111368
Open Access
Page 1 - Next Page

Scroll to top